Horseradish peroxidase-encapsulated chitosan nanoparticles for enzyme-prodrug cancer therapy

Xiaodan Cao, Chao Chen, Haijun Yu, Ping Wang

Research output: Contribution to journalArticle

14 Scopus citations


Among various enzyme-based therapies, enzyme-prodrug therapy (EPT) promises minimized side effects in that it activates non-toxic prodrugs locally where the enzymes are placed. The success of such an approach requires high enzyme stability against both structural denaturation and potential immunogenicity. This work examines the efficiency of nanoparticles for enzyme protection in EPT applications. Specifically, horseradish peroxidase (HRP)-encapsulated chitosan nanoparticles (HRP-CSNP) were constructed and examined with respect to stability enhancement. HRP-CSNP retained enzyme activity and had improved stability at 37 °C in the presence of a denaturant, urea. The nanoparticles effectively bound to the surface of human breast cancer cell Bcap37 and led to over 80 % cell death when applied with a prodrug indole-3-acetic acid.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalBiotechnology Letters
Issue number1
StatePublished - Jan 1 2015


  • Breast cancer
  • Chitosan nanoparticles
  • Enzyme-prodrug therapy
  • Horseradish peroxidase
  • Indole-3-acetic acid
  • Nanoparticles for cancer therapy
  • Protein stabilization

Fingerprint Dive into the research topics of 'Horseradish peroxidase-encapsulated chitosan nanoparticles for enzyme-prodrug cancer therapy'. Together they form a unique fingerprint.

  • Cite this